Park C - Search Results

1

Large liver cell dysplasia in hepatitis B virus x transgenic mouse liver and human chronic hepatitis B virus-infected liver.

Koo JS, Seong JK, Park C, Yu DY, Oh BK, Oh SH, Park YN. Koo JS, et al. Among authors: park c, park yn. Intervirology. 2005;48(1):16-22. doi: 10.1159/000082090. Intervirology. 2005. PMID: 15785085

2

Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B.

Koo JS, Kim H, Park BK, Ahn SH, Han KH, Chon CY, Park C, Park YN. Koo JS, et al. Among authors: park c, park bk, park yn. J Clin Gastroenterol. 2008 Jul;42(6):738-43. doi: 10.1097/MCG.0b013e318038159d. J Clin Gastroenterol. 2008. PMID: 18277883

3

Large liver cell change in hepatitis B virus-related liver cirrhosis.

Kim H, Oh BK, Roncalli M, Park C, Yoon SM, Yoo JE, Park YN. Kim H, et al. Among authors: park c, park yn. Hepatology. 2009 Sep;50(3):752-62. doi: 10.1002/hep.23072. Hepatology. 2009. PMID: 19585549

4

Induction of telomerase activity during an early burst of proliferation in pancreatic regeneration.

Oh BK, Seong JK, Lee JE, Chae KJ, Roh KJ, Park C, Park YN. Oh BK, et al. Among authors: park c, park yn. Cancer Lett. 2002 Dec 1;186(1):93-8. doi: 10.1016/s0304-3835(02)00320-8. Cancer Lett. 2002. PMID: 12183080

5

Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.

Paik SY, Park YN, Kim H, Park C. Paik SY, et al. Among authors: park c, park yn. Mod Pathol. 2003 Jan;16(1):86-96. doi: 10.1097/01.MP.0000047308.03300.9C. Mod Pathol. 2003. PMID: 12527718

6

Telomere shortening and telomerase reactivation in dysplastic nodules of human hepatocarcinogenesis.

Oh BK, Jo Chae K, Park C, Kim K, Jung Lee W, Han KH, Nyun Park Y. Oh BK, et al. Among authors: park c. J Hepatol. 2003 Nov;39(5):786-92. doi: 10.1016/s0168-8278(03)00395-7. J Hepatol. 2003. PMID: 14568262

7

p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis.

Park YN, Chae KJ, Kwon KW, Oh BK, Lee KS, Lee WJ, Park C. Park YN, et al. Among authors: park c. Hepatogastroenterology. 2003 Sep-Oct;50(53):1292-6. Hepatogastroenterology. 2003. PMID: 14571721

8

Expression of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in intraductal and nonintraductal growth type of cholangiocarcinoma.

Jo Chae K, Rha SY, Oh BK, Koo JS, Kim YJ, Choi J, Park C, Park YN. Jo Chae K, et al. Among authors: park c, park yn. Am J Gastroenterol. 2004 Jan;99(1):68-75. doi: 10.1046/j.1572-0241.2003.04025.x. Am J Gastroenterol. 2004. PMID: 14687144

9

Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype.

Kim H, Park C, Han KH, Choi J, Kim YB, Kim JK, Park YN. Kim H, et al. Among authors: park c, park yn. J Hepatol. 2004 Feb;40(2):298-304. doi: 10.1016/j.jhep.2003.10.023. J Hepatol. 2004. PMID: 14739102

10

Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.

Park YN, Chae KJ, Oh BK, Choi J, Choi KS, Park C. Park YN, et al. Among authors: park c. Hepatogastroenterology. 2004 Mar-Apr;51(56):396-400. Hepatogastroenterology. 2004. PMID: 15086168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,120 results

Search Page

Filters